Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
D
DaehanPharmaceutical
KOSDAQ:023910
DaehanPharmaceutical
KOSDAQ:023910
Price:
25 950
KRW
-0.57%
Market Closed
Market Cap:
₩155.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
DaehanPharmaceutical
KOSDAQ:023910
|
KR |
|
T
|
Television Francaise 1 SA
SWB:FSE
|
FR |
|
M
|
Magnum Ice Cream Company NV
LSE:MICC
|
NL |
|
Y
|
Yeh-Chiang Technology Corp
TPEX:6124
|
TW |
|
Solusi Bangun Indonesia Tbk PT
IDX:SMCB
|
ID |
|
M
|
Medco Energi Internasional Tbk PT
SWB:MEF
|
ID |
|
I
|
Isra Presisi Indonesia PT Tbk
IDX:ISAP
|
ID |
Wall St Price Targets
Price Forecast
Based on 3 analysts
Based on 3 analysts
+57% Upside
from
₩25 950
today
DaehanPharmaceutical (023910)’s 12-month stock price forecast through October 2027 has a consensus target of ₩40 800, implying 57% upside. The forecast is based on price targets from 3 Wall Street analysts.
DaehanPharmaceutical Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DaehanPharmaceutical's stock price target?
Price Target
40 800
KRW
40 800
KRW
According to Wall Street analysts, the average 1-year price target for DaehanPharmaceutical is 40 800 KRW with a low forecast of 40 400 KRW and a high forecast of 42 000 KRW.
What is the Revenue forecast for DaehanPharmaceutical?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for DaehanPharmaceutical?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 5%.
What is the Operating Income forecast for DaehanPharmaceutical?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for DaehanPharmaceutical?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for DaehanPharmaceutical?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 4%.